Jay Achar

916 total citations
26 papers, 312 citations indexed

About

Jay Achar is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Jay Achar has authored 26 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 13 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Jay Achar's work include Tuberculosis Research and Epidemiology (19 papers), Pneumonia and Respiratory Infections (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Jay Achar is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Pneumonia and Respiratory Infections (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Jay Achar collaborates with scholars based in United Kingdom, Sweden and Australia. Jay Achar's co-authors include Séverine Caluwaerts, James A. Seddon, Philipp du Cros, Jennifer Hughes, Alena Skrahina, Nargiza Parpieva, H. Simon Schaaf, Anthony J. Garcia‐Prats, Stefan Köhler and Jane Greig and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jay Achar

25 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Achar United Kingdom	11	274	148	78	41	40	26	312
Welile Sikhondze United States	12	348 1.3×	271 1.8×	127 1.6×	29 0.7×	9 0.2×	23	407
Jonathan M. Wortham United States	9	135 0.5×	206 1.4×	51 0.7×	28 0.7×	6 0.1×	26	387
Hannah Alsdurf Canada	7	412 1.5×	331 2.2×	135 1.7×	40 1.0×	7 0.2×	15	491
Robert Stevens United States	13	340 1.2×	248 1.7×	37 0.5×	53 1.3×	6 0.1×	21	409
C S Williams United Kingdom	4	237 0.9×	147 1.0×	90 1.2×	23 0.6×	9 0.2×	4	339
Beatrice Mutayoba Tanzania	9	183 0.7×	116 0.8×	32 0.4×	37 0.9×	4 0.1×	26	274
Sevim Ahmedov United States	9	366 1.3×	207 1.4×	74 0.9×	23 0.6×	3 0.1×	30	452
A Thomas India	9	412 1.5×	316 2.1×	134 1.7×	15 0.4×	11 0.3×	16	496
Ana Cláudia Carvalho Portugal	9	219 0.8×	160 1.1×	56 0.7×	23 0.6×	4 0.1×	33	349
Mahteme Haile Ethiopia	10	248 0.9×	294 2.0×	137 1.8×	34 0.8×	8 0.2×	22	444

Countries citing papers authored by Jay Achar

Since Specialization

Citations

This map shows the geographic impact of Jay Achar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Achar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Achar more than expected).

Fields of papers citing papers by Jay Achar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Achar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Achar. The network helps show where Jay Achar may publish in the future.

Co-authorship network of co-authors of Jay Achar

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Achar. A scholar is included among the top collaborators of Jay Achar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Achar. Jay Achar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Migliori, Giovanni Battista, Jay Achar, Ana Ciobanu, et al.. (2024). Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region. SHILAP Revista de lepidopterología. 1(3). 103–110. 1 indexed citations

Köhler, Stefan, et al.. (2024). Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024. Globalization and Health. 20(1). 51–51. 1 indexed citations

Rekart, Michael L., et al.. (2023). Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan. Microbiology Spectrum. 11(1). e0369822–e0369822. 4 indexed citations

Ranasinghe, Lasith, Jay Achar, Matthias I. Gröschel, et al.. (2022). Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data. The Lancet Global Health. 10(12). e1774–e1781. 18 indexed citations

Köhler, Stefan, et al.. (2022). The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan. SHILAP Revista de lepidopterología. 2(8). e0000567–e0000567. 4 indexed citations

Köhler, Stefan, et al.. (2022). Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan. ERJ Open Research. 8(1). 622–2021. 6 indexed citations

Howell, Pauline, et al.. (2022). Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities. Pathogens. 11(4). 381–381. 10 indexed citations

Sereda, Yuliia, et al.. (2021). Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study. Monaldi Archives for Chest Disease. 91(1). 4 indexed citations

Diktanas, Saulius, et al.. (2021). Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study. Monaldi Archives for Chest Disease. 91(1). 4 indexed citations

10.

Cros, Philipp du, Zinaida Tigay, Jane Greig, et al.. (2020). Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan. ERJ Open Research. 7(1). 537–2020. 13 indexed citations

11.

Horter, Shona, et al.. (2020). Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan. PLoS ONE. 15(11). e0242359–e0242359. 2 indexed citations

12.

Horter, Shona, et al.. (2020). Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan. BMC Infectious Diseases. 20(1). 675–675. 13 indexed citations

13.

Cros, Philipp du, et al.. (2020). A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis. BMC Infectious Diseases. 20(1). 298–298. 4 indexed citations

14.

Harausz, Elizabeth, Anthony J. Garcia‐Prats, James A. Seddon, et al.. (2017). New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. American Journal of Respiratory and Critical Care Medicine. 195(10). 1300–1310. 54 indexed citations

15.

Fernández, Lucía González, et al.. (2017). Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needs. Journal of the International AIDS Society. 20(S4). 21654–21654. 23 indexed citations

16.

Danis, Kostas, Jane Greig, Henriette de Valk, et al.. (2017). Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014–15. PLoS ONE. 12(5). e0176692–e0176692. 14 indexed citations

17.

Cros, Philipp du, D. Lister, Catherine Berry, et al.. (2017). Comparing shorter with conventional MDR-TB treatment in Uzbekistan: 2-month culture-conversion rates and treatment outcomes. Faculty of 1000 Research Ltd. 6. 913. 1 indexed citations

18.

Trauer, James M., Jay Achar, Nargiza Parpieva, et al.. (2016). Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Medicine. 14(1). 187–187. 15 indexed citations

19.

Greig, Jane, Jay Achar, Grazia Caleo, et al.. (2016). Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study. The Lancet Global Health. 4(7). e495–e501. 20 indexed citations

20.

Cros, Philipp du, et al.. (2016). Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications. The International Journal of Tuberculosis and Lung Disease. 20(4). 474–478. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact